Patofisiologi dan Manajemen Defisiensi Zat Besi pada Gagal Jantung: Sebuah Tinjauan Literatur

Sidhi Laksono, Yoseph Jeffry Hertanto

Abstract


The human body needs iron to function. Deficiency of iron causes inefficient use of oxygen and decreased oxygen availability. Iron deficiency is diagnosed when serum ferritin concentration is less than 100 ng/ml or concentration of ferritin is 100-299 ng/mL with transferrin saturation less than 20% in patients with heart failure. Several possible mechanisms are proposed as a cause for iron deficiency, such as; decreased food intake, increase hepcidin secretion that causes poor iron absorption, inflammation of reticuloendothelial system that causes iron leakage and loss of blood from gastrointestinal tract. Management of iron deficiency in heart failure is focused on iron supplementation, either orally or intravenously. Oral iron supplementation is generally considered less effective and may cause severe gastrointestinal side effects. Current guidelines also support use of IV therapy. Currently, several novel therapies in development focus on iron metabolism.

Full Text:

PDF

References


  1. Anand IS, Gupta P. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies. Circulation. 2018;138(1):80–98.
  2. Beavers CJ, Ambrosy AP, Butler J, Davidson BT, Gale SE, PIÑA IL, et al. Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America. J Card Fail. 2023 May;00(00).
  3. Dziegala M, Josiak K, Kasztura M, Kobak K, von Haehling S, Banasiak W, et al. Iron deficiency as energetic insult to skeletal muscle in chronic diseases. J Cachexia Sarcopenia Muscle. 2018;9(5):802–15.
  4. Melenovsky V, Petrak J, Mracek T, Benes J, Borlaug BA, Nuskova H, et al. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur J Heart Fail. 2017;19(4):522–30.
  5. Masini G, Graham FJ, Pellicori P, Cleland JGF, Cuthbert JJ, Kazmi S, et al. Criteria for Iron Deficiency in Patients With Heart Failure. J Am Coll Cardiol. 2022;79(4):341–51.
  6. Inamdar AA, Inamdar AC. Heart failure: Diagnosis, management and utilization. J Clin Med. 2016;5(7).
  7. Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF, et al. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. J Am Coll Cardiol. 2017;70(20):2476–86.
  8. Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner W, S. P. Lam C, et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol. 2017;92(10):1068–78.
  9. von Haehling S, Gremmler U, Krumm M, Mibach F, Schön N, Taggeselle J, et al. Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry. Clin Res Cardiol. 2017;106(6):436–43.
  10. Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, Banasiak W, et al. Iron deficiency in chronic heart failure: An international pooled analysis. Am Heart J. 2013;165(4):575-582.e3.
  11. Rocha BML, Cunha GJL, Menezes Falcão LF. The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach. J Am Coll Cardiol. 2018;71(7):782–93.
  12. Van Der Wal HH, Beverborg NG, Dickstein K, Anker SD, Lang CC, Ng LL, et al. Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use. Eur Heart J. 2019;40(44):3616–25.
  13. Moliner P, Enjuanes C, Tajes M, Cainzos-Achirica M, Lupón J, Garay A, et al. Association between norepinephrine levels and abnormal iron status in patients with chronic heart failure: Is iron deficiency more than a comorbidity? J Am Heart Assoc. 2019;8(4):1–10.
  14. Tajes M, Díez-López C, Enjuanes C, Moliner P, Ferreiro JL, Garay A, et al. Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells. Cell Biosci. 2021;11(1):1–18.
  15. Silvestre OM, Gonçalves A, Nadruz W, Claggett B, Couper D, Eckfeldt JH, et al. Ferritin levels and risk of heart failure—the Atherosclerosis Risk in Communities Study. Eur J Heart Fail. 2017;19(3):340–7.
  16. Beverborg NG, Klip IjT, Meijers WC, Voors AA, Vegter EL, Van Der Wal HH, et al. Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients. Circ Hear Fail. 2018;11(2).
  17. Babitt JL, Eisenga MF, Haase VH, Kshirsagar A V., Levin A, Locatelli F, et al. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int. 2021;99(6):1280–95.
  18. Ponikowski P, Van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015;36(11):657–68.
  19. Savarese G, von Haehling S, Butler J, Cleland JGF, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Eur Heart J. 2023;44(1):14–27.
  20. Rizzo C, Carbonara R, Ruggieri R, Passantino A, Scrutinio D. Iron Deficiency: A New Target for Patients With Heart Failure. Front Cardiovasc Med. 2021;8(August).
  21. Alnuwaysir RIS, Hoes MF, van Veldhuisen DJ, van der Meer P, Beverborg NG. Iron deficiency in heart failure: Mechanisms and pathophysiology. J Clin Med. 2022;11(1).
  22. Sierpinski R, Josiak K, Suchocki T, Wojtas-Polc K, Mazur G, Butrym A, et al. High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality. Eur J Heart Fail. 2021;23(6):919–32.
  23. Jankowska EA, Von Haehling S, Anker SD, MacDougall IC, Ponikowski P. Iron deficiency and heart failure: Diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013;34(11):816–26.
  24. Cohen-Solal A, Leclercq C, Deray G, Lasocki S, Zambrowski JJ, Mebazaa A, et al. Iron deficiency: An emerging therapeutic target in heart failure. Heart. 2014;100(18):1414–20.
  25. Fisher R. Management of iron deficiency in chronic heart failure. Res Rev Publ. 2019;
  26. Loncar G, Obradovic D, Thiele H, von Haehling S, Lainscak M. Iron deficiency in heart failure. ESC Hear Fail. 2021;8(4):2368–79.
  27. Ghafourian K, Shapiro JS, Goodman L, Ardehali H. Iron and Heart Failure: Diagnosis, Therapies, and Future Directions. JACC Basic to Transl Sci. 2020;5(3):300–13.
  28. Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, et al. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure. N Engl J Med. 2013;368(13):1210–9.
  29. Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Michael Felker G, et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency the IRONOUT HF randomized clinical trial. JAMA - J Am Med Assoc. 2017;317(19):1958–66.
  30. Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;126(17):1981–9.
  31. Gstrein C, Meyer MR, Anabitarte P. Iron substitution in the treatment of chronic heart failure. Swiss Med Wkly. 2017;147(June):1–8.
  32. Fishbane S, Block GA, Loram L, Neylan J, Pergola PE, Uhlig K, et al. Effects of ferric citrate in patients with nondialysis-dependent CKD and iron deficiency anemia. J Am Soc Nephrol. 2017;28(6):1851–8.
  33. McCullough PA, Uhlig K, Neylan JF, Pergola PE, Fishbane S. Usefulness of Oral Ferric Citrate in Patients With Iron-Deficiency Anemia and Chronic Kidney Disease With or Without Heart Failure. Am J Cardiol. 2018;122(4):683–8.
  34. von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. Iron Deficiency in Heart Failure: An Overview. JACC Hear Fail. 2019;7(1):36–46.




DOI: https://doi.org/10.18860/jim.v7i2.21513

Refbacks

  • There are currently no refbacks.


 

Editorial Office:

Faculty of Medical and Health Sciences,
Universitas Islam Negeri Maulana Malik Ibrahim
Gedung Ibnu Thufail Lt.1, Jln. Locari, Desa Tlekung, Kota Batu
Phone (+62) 85746163772, (+62) 85259506000, Faximile (+62) 341 558933
e-mail: medicaljournal@uin-malang.ac.id

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.